Identification of disease-associated proteins by proteomic approach in ankylosing spondylitis

Biochemical and Biophysical Research Communications

Volumn 357, Issue 2, 2007, Pages 531-536

  Liu, Jing ^a   Zhu, Ping ^a   Peng, Jiarou ^b   Li, Keqiu ^c   Du, Jinwei ^a   Gu, Jiangying ^a   Ou, Yuan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Ankylosing spondylitis; Epitope prediction; Haptoglobin precursor; Serum proteomic analysis

Indexed keywords

EPITOPE; HAPTOGLOBIN; HLA B ANTIGEN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPTOGLOBINS; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PROTEOME; SPONDYLITIS, ANKYLOSING;

EID: 34247143854     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.179     Document Type: Article

References (31)

1. Brown M.A., Laval S.H., and Brophy Calin S.A. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 59 (2000) 883-886
2. Khan M.A. HLA-B27 polymorphism and association with disease. J. Rheumatol. 27 (2000) 1110-1114
3. Benjamin R., and Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11 (1990) 137-142
4. Yan J.X., Wait R., Berkelman T., Berkelman T., Harry R.A., Westbrook J.A., Wheeler C.H., and Dunn M.J. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21 (2000) 3666-3672
5. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
6. Parker K.C., Bednarek M.A., and Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152 (1994) 163-175
7. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., and Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50 (1999) 213-219
8. Atagunduz P., Appel H., Kuon W., Wu P., Thiel A., Kloetzel P.M., and Sieper J. HLA-B27-restricted CD8+ T cell response to cartilage-derived self eptides in ankylosing spondylitis. Arthritis Rheum. 52 (2005) 892-901
9. Kuon W., Kuhne M., Busch D.H., Atagunduz P., Seipel M., Wu P., Morawietz L., Fernahl G., Appel H., Weiss E.H., Krenn V., and Sieper J. Identification of novel human aggrecan T cell epitopes in HLA-B27 transgenic mice associated with spondyloarthropathy. J. Immunol. 173 (2004) 4859-4866
10. Lee S., Khare S.D., Griffiths M.M., Luthra H.S., and David C.S. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease. Hum. Immunol. 61 (2000) 140-147
11. Gross D.M., Forsthuber T., Tary-Lehmann M., Etling C., Ito K., Nagy Z.A., Field J.A., Steere A.C., and Hube B.T. Identification of LFA-1 as candidate autoantigen in treatment-resistant Lyme arthritis. Science 281 (1998) 703-706
12. Fiorillo M.T., Maragno M., Butler R., Dupuis M.L., and Sorrentino R. CD8+ T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106 (2000) 47-53
13. Kowalczewska M., Fenollar F., Lafitte D., and Raoult D. Identification of candidate antigen in Whipple's disease using a serological proteomic approach. Proteomics 6 (2006) 3294-3305
14. Feng J.T., Liu Y.K., Song H.Y., Dai Z., Qin L.X., Almofti M.R., Fang C.Y., Lu H.J., Yang P.Y., and Tang Z.Y. Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis. Proteomics 5 (2005) 4581-4588
15. Juan H.F., Chen J.H., Hsu W.T., Huang S.C., Chen S.T., Yi-Chung L.J., Chang Y.W., Chiang C.Y., Wen L.L., Chan D.C., Liu Y.C., and Chen Y.J. Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics 4 (2004) 2766-2775
16. Hanley J.M., and Heath E.C. A novel proteolytic activity in serum processes rat prohaptoglobin. Arch. Biochem. Biophys. 239 (1985) 404-419
17. Misumi Y., Tanaka Y., and Ikehara Y. Biosynthesis, intracellular processing and secretion of haptoglobin in cultured rat hepatocytes. Biochem. Biophys. Res. Commun. 114 (1983) 729-736
18. Tseng C.F., Lin C.C., Huang H.Y., Liu H.C., and Mao S.J. Antioxidant role of human haptoglobin. Proteomics 4 (2004) 2221-2228
19. Yoneda T., Alsina M.A., Chavez J.B., Bonewald L., Nishimura R., and Mundy G.R. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J. Clin. Invest. 87 (1991) 977-985
20. Oh S.K., Kim S.H., and Walker J.E. Interference with immune response at the level of generating effector cells by tumor-associated haptoglobin. J. Natl. Cancer Inst. 82 (1990) 934-940
21. Ye B., Cramer D.W., Skates S.J., Gygi S.P., Pratomo V., Fu L., Horick N.K., Licklider L.J., Schorge J.O., Berkowitz R.S., and Mok S.C. Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. Clin. Cancer Res. 9 (2003) 2904-2911
22. Ahmed N., Barker G., Oliva K.T., Hoffmann P., Riley C., Reeve S., Smith A.I., Kemp B.E., Quinn M.A., and Rice G.E. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer. Br. J. Cancer 91 (2004) 129-140
23. Pamer E.G., Harty J.T., and Bevan M.J. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353 (1991) 852-855
24. Rotzschke O., Falk K., Stevanovic S., Jung G., Walden P., and Rammensee H.G. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21 (1991) 2891-2894
25. Falk K., Rotzschke O., Stevanovic S., Jung G., and Rammensee H.G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351 (1991) 290-296
26. Xiaoling G., Ying L., Jing L., Huifang L., Xia Z., Qingqing F., and Ping Z. Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain. Cancer Immunol. Immunother. 54 (2005) 1106-1114
27. Neumann F., Wagner C., Preuss K.D., Kubuschok B., Schormann C., Stevanovic S., and Pfreundschuh M. Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cells. Blood 106 (2005) 3105-3113
28. Hansson L., Rabbani H., Fagerberg J., Osterborg A., and Mellstedt H. T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma. Blood 101 (2003) 4930-4936
29. *0201 molecules. Leuk. Res. 30 (2006) 1293-1298
30. Luckey C.J., Marto J.A., Partridge M., Hall E., White F.M., Lippolis J.D., Shabanowitz J., Hunt D.F., and Engelhard V.H. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors. J. Immunol. 167 (2001) 1212-1221
31. Khan M.A., Kushner I., and Braun W.E. Association of HLA-A2 with uveitis in HLA-B27 positive patients with ankylosing spondylitis. J. Rheumatol. 8 (1981) 295-298